|
|
|
|
|
by mmastrac
2794 days ago
|
|
> a lower incidence of adverse events reported (20.7%) compared with placebo (24.6%) Isn't that an odd result? Unless the drug is treating underlying viral issues that might not have been identified prior, it should be on par with placebo, no? |
|
> The knowledge about taking medication or the anxiety about medication effects and illness course can cause patients to monitor symptoms in more detail, resulting in an amplified perception of benign sensations and physical symptoms.
[1]: https://dx.doi.org/10.1001/archinte.166.2.155